Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 5:13 pm Unchanged | 2021-02-12 | 13D | Innoviva, Inc. INVA | GSK plc | 32,005,260 31.600% | 0 (Unchanged) | Filing History |
| 2021-02-12 5:12 pm Purchase | 2020-12-31 | 13G | Genocea Biosciences, Inc. GNCA | GSK plc | 5,217,389 9.900% | 1,540,622 (+41.90%) | Filing History |
| 2021-02-12 5:10 pm Sale | 2020-12-31 | 13G | Progyny, Inc. PGNY | GSK plc | 2,926,957 3.400% | -7,600,000 (-72.20%) | Filing History |
| 2021-01-29 09:54 am Purchase | 2020-12-31 | 13G | GSK plc GSK | BlackRock Inc. BLK | 370,040,405 7.500% | 1,103,427 (+0.30%) | Filing |
| 2020-12-07 5:08 pm Sale | 2020-11-05 | 13D | Spero Therapeutics, Inc. SPRO | GSK plc | 1,740,606 6.400% | -78,872 (-4.33%) | Filing History |
| 2020-12-07 5:06 pm Sale | 2020-11-05 | 13D | Bicycle Therapeutics plc BCYC | GSK plc | 1,894,831 8.900% | -20,444 (-1.07%) | Filing History |
| 2020-11-30 5:05 pm Purchase | 2020-11-20 | 13G | F-star Therapeutics, Inc. FSTX | GSK plc | 803,922 8.900% | 803,922 (New Position) | Filing History |
| 2020-11-06 5:26 pm Purchase | 2020-10-29 | 13D | Turning Point Therapeutics, Inc. TPTX | GSK plc | 2,273,618 4.900% | 4,958 (+0.22%) | Filing History |